Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies
- PMID: 38706873
- PMCID: PMC11066302
- DOI: 10.3389/fpain.2024.1346053
Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies
Abstract
Despite research advances and urgent calls by national and global health organizations, clinical outcomes for millions of people suffering with chronic pain remain poor. We suggest bringing the lens of complexity science to this problem, conceptualizing chronic pain as an emergent property of a complex biopsychosocial system. We frame pain-related physiology, neuroscience, developmental psychology, learning, and epigenetics as components and mini-systems that interact together and with changing socioenvironmental conditions, as an overarching complex system that gives rise to the emergent phenomenon of chronic pain. We postulate that the behavior of complex systems may help to explain persistence of chronic pain despite current treatments. From this perspective, chronic pain may benefit from therapies that can be both disruptive and adaptive at higher orders within the complex system. We explore psychedelic-assisted therapies and how these may overlap with and complement mindfulness-based approaches to this end. Both mindfulness and psychedelic therapies have been shown to have transdiagnostic value, due in part to disruptive effects on rigid cognitive, emotional, and behavioral patterns as well their ability to promote neuroplasticity. Psychedelic therapies may hold unique promise for the management of chronic pain.
Keywords: biopsychosocial; chronic pain; complexity; mindfulness; neuroplasticity; psychedelics; systems theory.
© 2024 Armstrong, Castellanos and Christie.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11066302/bin/fpain-05-1346053-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11066302/bin/fpain-05-1346053-g002.gif)
Similar articles
-
Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.Neurosurgery. 2023 Apr 1;92(4):680-694. doi: 10.1227/neu.0000000000002275. Epub 2022 Dec 8. Neurosurgery. 2023. PMID: 36512813 Free PMC article. Review.
-
Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research.Front Psychiatry. 2021 Nov 12;12:735427. doi: 10.3389/fpsyt.2021.735427. eCollection 2021. Front Psychiatry. 2021. PMID: 34867525 Free PMC article.
-
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.Front Psychiatry. 2021 Dec 17;12:800072. doi: 10.3389/fpsyt.2021.800072. eCollection 2021. Front Psychiatry. 2021. PMID: 34975593 Free PMC article. Review.
-
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.Neuropharmacology. 2023 Aug 1;233:109528. doi: 10.1016/j.neuropharm.2023.109528. Epub 2023 Apr 2. Neuropharmacology. 2023. PMID: 37015315 Review.
-
Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.J Acad Consult Liaison Psychiatry. 2021 Jul-Aug;62(4):460-471. doi: 10.1016/j.jaclp.2020.12.011. Epub 2021 Jan 21. J Acad Consult Liaison Psychiatry. 2021. PMID: 34210406
References
LinkOut - more resources
Full Text Sources